Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,2,1.06 [1.02-1.11],0.00383009261528611,trans
PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,2,1.07 [1-1.15],0.0415676647658125,trans
PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,10,1.03 [0.99-1.07],0.10304548508234,trans
PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,10,1.03 [0.99-1.07],0.116067977720247,trans
PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,4,0.97 [0.93-1.01],0.14511732160242,trans
PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Wald ratio,1,1.05 [0.98-1.12],0.188801598011944,trans
PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,Chapter II Neoplasms,C3_BREAST_EXALLC,Inverse variance weighted,46,1.01 [0.99-1.04],0.413904039173139,trans
